DRMA
Dermata Therapeutics, Inc.$0.76-0.01 (-1.30%)Prev Close$0.78·MCap$3.9M·P/E—·Vol93.4K·Yield—
▲
Buys (12M)
1
$1.3K
▼
Sells (12M)
1
$13.09
◆
Net Activity
Net Buyer
$1.3K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Dermata Therapeutics, Inc. (DRMA) has been dominated by buying, with 1 insider purchase totaling $1.3K and 1 insider sale totaling $13.09. The most recent insider transaction was by Scott Kathleen D. (director), who sold $13.09 worth of shares on Jun 16, 2026. Dermata Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.9M.
DRMA Insider Trading Activity
DRMA Insider Buying Activity
The following table shows recent insider purchases of Dermata Therapeutics, Inc. (DRMA) stock reported via SEC Form 4 filings.
DRMA Insider Selling Activity
The following table shows recent insider sales of Dermata Therapeutics, Inc. (DRMA) stock reported via SEC Form 4 filings.